|
ATP9A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.463600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.676000E-01 |
| Normal-vs-Stage2 |
6.400800E-01 |
| Normal-vs-Stage3 |
2.257200E-01 |
| Normal-vs-Stage4 |
4.665600E-01 |
| Stage1-vs-Stage2 |
9.705600E-01 |
| Stage1-vs-Stage3 |
5.110600E-01 |
| Stage1-vs-Stage4 |
3.318400E-01 |
| Stage2-vs-Stage3 |
5.980800E-01 |
| Stage2-vs-Stage4 |
4.901000E-01 |
| Stage3-vs-Stage4 |
2.773000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.741800E-01 |
| Normal-vs-AfricanAmerican |
9.012000E-01 |
| Normal-vs-Asian |
3.971000E-01 |
| Caucasian-vs-AfricanAmerican |
1.933020E-01 |
| Caucasian-vs-Asian |
1.028150E-01 |
| AfricanAmerican-vs-Asian |
6.619000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.983800E-01 |
| Normal-vs-Female |
9.555200E-03 |
| Male-vs-Female |
3.956100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.533400E-01 |
| Normal-vs-Extreme_Weight |
9.449000E-01 |
| Normal-vs-Obese |
9.990100E-02 |
| Normal-vs-Extreme_Obese |
2.604100E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.079600E-01 |
| Normal_Weight-vs-Obese |
7.783800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.355900E-02 |
| Extreme_Weight-vs-Obese |
2.596000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.853500E-02 |
| Obese-vs-Extreme_Obese |
4.010200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.193200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.387700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.158200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.764200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.821000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.686300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.194500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.258900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.761600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.955800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.662000E-01 |
| Normal-VS-Type2 PRCC |
6.120200E-01 |
| Normal-VS-KIRP CIMP |
2.039400E-01 |
| Normal-VS-Unclassified PRCC |
7.773900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.326000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.766200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.316500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.127500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.109600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.136800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.096000E-01 |
| Normal-vs-N1 |
1.116950E-01 |
| Normal-vs-N2 |
8.176400E-01 |
| N0-vs-N1 |
3.364100E-02 |
| N0-vs-N2 |
6.811200E-01 |
| N1-vs-N2 |
5.778800E-01 |
|
|
